TORONTO, Jan. 22, 2025 /CNW/ - Mackenzie Investments ("Mackenzie") today released its 2025 ETF Outlook (the "Outlook"), examining the growth of the exchange-traded funds ("ETF") industry in Canada ...

In our Energy Outlook, we detail our forecasts on fossil fuel, renewables, carbon capture and storage, hydrogen, and utilities ...

Fintel reports that on January 21, 2025, Cantor Fitzgerald downgraded their outlook for Keros Therapeutics (NasdaqGM:KROS) ...

H.C. Wainwright maintained a positive outlook on Axsome Therapeutics (NASDAQ:AXSM), reiterating a Buy stock rating with a ...

The Bitcoin market continues to see a lot of noisy trading, but more than anything else, this is a market that will continue to see buyers on dips, as the market remains very stout overall. At this ...

Kairos Pharma Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company developing therapies to surmount current cancer drug resistance and immune suppression, provides an overview of key ...

A critical malware threat has been discovered targeting Gmail and Outlook users, with malicious code hidden in email images.

Chardan Capital analyst Daniil Gataulin maintained a Hold rating on Outlook Therapeutics (OTLK – Research Report) today and set a price target ...

The prestigious 10th Edition of the Outlook Business Spotlight Awards - Achievers Awards 2024 concluded successfully on 21st ...

Soft skills are now required for in-house lawyers seeking appointments as general counsel or chief compliance officers in the ...

Global growth is projected at 3.3 percent both in 2025 and 2026, broadly unchanged from the October 2024 World Economic ...

Outlook Therapeutics Inc (OTLK) stock saw a modest uptick, ending the day at $2.23 which represents a slight increase of $0.04 or 1.83% from the prior close of $2.19. The stock opened at $2.19 and ...